STARJEMZA

LaunchmAb

ustekinumab-hmny

Bio-Thera Solutions
BLASUBCUTANEOUSINJECTABLE
Approved
May 2025
Lifecycle
Launch
Competitive Pressure
30/100

Mechanism of Action

Interleukin-12 Antagonists

Pharmacologic Class:

Interleukin-12 Antagonist

Company
BS
Bio-Thera Solutions
China - Guangzhou
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers